View in EDS HTML Full Text PDF Full Text

Real-world practices of low-molecular-weight heparin for venous thromboembolism prophylaxis in patients hospitalized with COVID-19: a multicenter prospective study from China.

Saved in:
Bibliographic Details
Title: Real-world practices of low-molecular-weight heparin for venous thromboembolism prophylaxis in patients hospitalized with COVID-19: a multicenter prospective study from China.
Authors: Xu, Feiya1 (AUTHOR), Tao, Yuzhi2,3 (AUTHOR), Chen, Lijun4 (AUTHOR), Zhang, Yunhui5 (AUTHOR), Wang, Binliang6 (AUTHOR), Han, Jing7 (AUTHOR), Deng, Chaosheng8 (AUTHOR), Liu, Weijia7 (AUTHOR), Fan, Guohui3 (AUTHOR), Liang, Rui9 (AUTHOR), Chen, Zhaofei3,10 (AUTHOR), Chen, Yinong3,10 (AUTHOR), Zhen, Kaiyuan3,10 (AUTHOR), Zhang, Yunxia3 (AUTHOR), Zhang, Zhu3 (AUTHOR), Zhang, Shuai3 (AUTHOR), Wan, Jun11 (AUTHOR), Xie, Wanmu3 (AUTHOR), Yang, Peiran12 (AUTHOR), Kang, YuTing13 (AUTHOR)
Source: Thrombosis Journal. 6/20/2025, Vol. 23 Issue 1, p1-10. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14779560
DOI:10.1186/s12959-025-00741-9